Literature DB >> 3052824

Serotonergic mechanisms of depression.

G Curzon1.   

Abstract

Data gathered for the past 30 years suggest 5-HT abnormalities in depression, but it is still unknown whether serotonin has a major causal role. Depression is often regarded as a result of defective serotonergic function, but it is also possible that this defect is an indication of an ineffective compensatory response to abnormally high serotonergic function. Abnormal 5-HT function could be a result of disturbances at various pre- and postsynaptic levels. The disturbances reported at most of these levels are largely subject to dispute. Specific abnormalities can occur in specific subgroups and can be either state or trait dependent. Nevertheless, 5-HT hypotheses have been helpful for the development of drugs, although even here there is disagreement as to their actual mechanism of action. Two recent developments can help to clear up these uncertainties. First, the discovery of many types of 5-HT receptors and the increasing availability of drugs specifically related to them provides new adaptable research tools as well as the possibility of new therapies. Second, data provided by studies of humans and by animal models suggest that vulnerability to depression depends on disturbances of both 5-HT and the hypothalamohypophysial axis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3052824

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN: 0362-5664            Impact factor:   1.592


  7 in total

Review 1.  Agonistic behavior: a model, experimental studies, and perspectives.

Authors:  N N Kudryavtseva
Journal:  Neurosci Behav Physiol       Date:  2000 May-Jun

Review 2.  Tianeptine: a review of its use in depressive disorders.

Authors:  A J Wagstaff; D Ormrod; C M Spencer
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 3.  Sertraline. A pharmacoeconomic evaluation of its use in depression.

Authors:  R Davis; M I Wilde
Journal:  Pharmacoeconomics       Date:  1996-10       Impact factor: 4.981

4.  Metabotropic glutamate receptor subtype 8 in the amygdala modulates thermal threshold, neurotransmitter release, and rostral ventromedial medulla cell activity in inflammatory pain.

Authors:  Enza Palazzo; Ida Marabese; Marie Soukupova; Livio Luongo; Serena Boccella; Catia Giordano; Vito de Novellis; Francesca Rossi; Sabatino Maione
Journal:  J Neurosci       Date:  2011-03-23       Impact factor: 6.167

5.  Serotonin modulation of sensory inputs to the lateral amygdala: dependency on corticosterone.

Authors:  G E Stutzmann; B S McEwen; J E LeDoux
Journal:  J Neurosci       Date:  1998-11-15       Impact factor: 6.167

Review 6.  Tianeptine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depression and coexisting anxiety and depression.

Authors:  M I Wilde; P Benfield
Journal:  Drugs       Date:  1995-03       Impact factor: 9.546

Review 7.  Novel Psychoactive Substances: The Razor's Edge between Therapeutical Potential and Psychoactive Recreational Misuse.

Authors:  Beatriz Correia; Joana Fernandes; Maria João Botica; Carla Ferreira; Alexandre Quintas
Journal:  Medicines (Basel)       Date:  2022-03-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.